Thu, Nov 20, 2014 - Page 3 News List

FDA’s Medado probe ongoing

FALSE RESULTS:A media report alleged that a medical equipment supplier sold expired cancer screening products, falsifying labels in order to meet sales targets

By Stacy Hsu  /  Staff reporter

The Food and Drug Administration (FDA) said yesterday that it has yet to ascertain whether medical examination equipment seller Medado Trading Co (鈦化企業) tampered with the expiry date on its cancer screening products more than once and how many hospitals it had sold the potentially problematic devices to.

“As Taipei-based Medado is only a sales agency rather than a licensed medical equipment manufacturer, we cannot track its sales records via the National Health Insurance program’s system and have to rely on local hospitals to double-check if they have ever purchased the screening tests that were allegedly tampered with,” FDA Division of Medical Devices and Cosmetics Section Chief Lue Tsai-luen (呂在綸) told a press conference in Taipei.

Lue was responding to a report in Chinese-language newspaper the Apple Daily yesterday which said that Medado’s proprietor, Wang Yu-ching (王裕景), and sales manager Kuan Pen-yi (官本義) have been charged by Taipei prosecutors with fraud, forgery and violation of the Pharmaceutical Affairs Act (藥事法).

It is alleged that the two changed expiration date labels on four kinds of cancer screening tests they procured from a registered pharmaceutical manufacturing company in 2011.

The tests included the CA19-9 screening test for pancreatic cancer, the alpha-fetoprotein (AFP) screening test for liver cancer, the prostate specific antigen (PSA) screening test for prostate cancer, and the serum free thyroxine (FT4) screening test for hyperthyroidism, the report said.

Citing an anonymous whistleblower, the report alleged that Wang and Kuan commissioned a company to attach a new label with an expiration date that was one month past the date on the original, to an entire batch of the tests it bought in 2011.

“The pair did so for the sole purpose of meeting the sales requirements in its contract with the Tri-Service General Hospital’s Songshan Branch, which said that the screening tests Medado provided must have more than six months remaining on their expiration dates,” the report quoted the informant as saying.

“However, the expiration date for the batch it purchased in 2011 was [allegedly] one month shorter than the required minimum shelf life. So they did what they did out of fear that the products might be rejected by the hospital and that they might be forced to shoulder the loss,” the informant was quoted as saying.

Lue said screening tests’ expiry dates are meant to offer guidance to medical practitioners on how long the tests would remain effective and accurate after production.

“That means an expired screening test could yield false positive or negative results, and therefore risks delaying cancer treatments that might be needed,” Lue said.

Lue said Medado’s allegedly illegal practice violated Article 84 of the Pharmaceutical Affairs Act, which carries a prison term of less than three years and a fine not exceeding NT$100,000 (US$3,300).

He also urged medical institutions that have had business dealings with Medado to check if the expiration date labels on products other than the screening tests in question have also been tampered with.

Later yesterday, Tri-Service General Hospital’s Songshan Branch dismissed speculation that it might have administered expired screening tests, saying that the problematic batch was used in its entirety less than one month after purchase.

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. Final decision will be at the discretion of the Taipei Times.

TOP top